ArticleFEBS open bio2026

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non-small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival.

Stuti Goel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.